Psychostimulants Flashcards

1
Q

Amphetamine MOA

A

Agonists of monoamine neurotransmitters

Mainly promote RELEASE of biogenic amines from storage sites by INHIBITING VMAT

Normally VMAT functions to store DOPAMINE in intracellular vesicles
-> By inhibiting VMAT you force Dopamine and Norepinephrine to be more freely available in the cytosol for release from presynaptic neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Main Concerns when prescribing Amphetamines and Amphetamine-like agents

A

1) Stimulant effects on
CNS, GI, Cardiovascular

2) Psychosis With high doses
3) Psychological dependence

4) Withdrawal reactions
- > Depressed mood, fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Main effect of Norepinephrine release triggered by ADHD drugs

A

Stimulation of Alpha 1 Receptors

  • > Alpha 1 Adrenergic Receptor activation leads to Vasoconstriction
  • > Increases systemic vascular resistance -> blood pressure goes up as a result
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of Overdose with ADHD medications

A

1) Control cardiovascular hemodynamics
- > Eg, Alpha blockers (Cause VASODILATION), Nitrates

2) Sedatives
- > Eg, benzodiazepines

3) Activated charcoal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Methylphenidate

A

= Ritalin

  • > Most commonly used Amphetamine
  • > you are less concerned about cardiovascular effects vs. other amphetamines because Ritalin causes less release of Norepinephrine into the periphery (thus lower risk of Cardiovascular effects like high BP and potential infarction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Schedule II drugs (like Vyvanse, ADHD drugs)

A

1) Prescribed in restricted quantities
2) Must be filled within specific number of days
3) Have Signature & DEA number
4) Telephone for emergencies only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Atomoxetine (Strattera)

A

Mechanism:
Selective INHIBITOR of norepinephrine transport (Inhibitor of NE reuptake -> NE stays in the Synaptic cleft for longer)

Extensive HEPATIC metabolism (CYP 2D6)

Schedule IV drug

Concerns: SUICIDE in a smaller number of patients
1) CNS

2) GI
3) Cardiovascular

Others:

  • Dry mouth, urinary retention
  • Priapism (painful, prolonged ERECTIONS)
  • Drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Guanfacine (Intuniv -> DRUG DAT DONT MAKE NO SENSE)

A

MOA: Centrally acting Alpha-2 receptor AGONIST
-> (MOA for ADHD UNCLEAR)
Main side effects:
1) Sedation
2) Hypotension
Schedule IV drug
COUNTERINTUITIVE MOA: Other ADHD drugs cause more release of Norepinephrine, but this drug activates the auto-inhibitory Alpha-2 receptor pathway, which leads to lowered production of Catecholamines ‘ (like NE and Epinephrine)
Similar MOA to Clonidine (used to lower BP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Caffeine and Adenosine

A

Caffeine is an Adenosine Receptor ANTAGONIST
-> (opposite effect as Adenosine)

Adenosine suppresses CNS activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmalogical Effects of Caffeine

A

1) Increased arousal & alertness
2) Cardiac & smooth muscle effects
3) Anorexia
4) Diuresis

Mechanism:
Adenosine receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Effects of Adenosine on Presynaptic and Postsynaptic Neurotransmission

A

Adenosine has both presynaptic and postsynaptic effects on neurotransmission

Presynaptic:

  • Closes Ca++ channels
  • Lowers NT release

Postsynaptic:

  • Opens K+ channels
  • Hyperpolarizes postsynaptic neuron
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Theophylline

A

A metabolite of Caffeine that is like a SUPER-caffeine
-> (you need to MONITOR blood levels of Theophylline because at high levels this can be dangerous)

Like Caffeine, Theophylline causes Vasoconstriction

Form of Caffeine that is used in Excedrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Concerns about Excessive Caffeine Production

A

1) CNS
2) GI
3) Cardiovascular
4) Tolerance & withdrawal

5) Guarana & presence in supplements
- > Plant that has a lot of caffeine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Modafinil (Provigil) AND armodafinil (Nuvigil) MOA:

A
  • Blocks dopamine transporter (Inhibits Dopamine Reuptake)
  • > Increases synaptic dopamine

Used for excessive sleepiness:

  • Narcolepsy
  • Shift work
  • Obstructive sleep apnea

Schedule IV drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gamma-Hydroxybutyrate (GHB)

A

DATE RAPE DRUG

MOA:
Exhibits Dopamine-like effects and GABA-like effects

AKA: Sodium oxybate (Xyrem)

Used for:
1) Cataplexy (strong emotion or laughter causes a person to suffer sudden physical collapse though remaining conscious)

2) Refractory NARCOLEPSY

Schedule III drug
-> If a child takes even a little bit of this medicine, it could cause DEATH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anorexiants

A

1) Phentermine (Ionamin, others)
- > NE transporter inhibition
- > Sometimes in combination with extended-release topiramate (Qsymia)

2) Lorcaserin (Belviq)
- > 5HT2C receptor AGONIST

3) Bupropion + Naltrexone (Contrave)
- > Dopamine Reuptake inhibitor
- > ALSO: OPOID RECEPTOR ANTAGONIST

17
Q

Phentermine

A

Anorexiant

(AKA Ionamin, others)

  • MOA: NE transporter inhibition
  • > Sometimes in combination with extended-release topiramate (Qsymia)
18
Q

Lorcaserin (Belviq)

A

Anorexiant

-> 5HT2C receptor AGONIST (specific Serotonin receptor)

19
Q

Bupropion + Naltrexone (Contrave)

A

Anorexiant

  • > Dopamine Reuptake inhibitor
  • > ALSO: OPOID RECEPTOR ANTAGONIST
20
Q

Anorexiants that are NO LONGER USED (because they caused too many Cardiovascular problems and were banned by the FDA)

A

Fenfluramine & Dexfenfluramine
Serotonin modulation

Sibutramine (Meridia)
NE & serotonin transporter inhibition

21
Q

Indications for Anorexiant Use

A
  • For use in those who are obese (BMI > 30 kg/m2) & unresponsive to lifestyle modification
  • Or overweight (BMI > 27 kg/m2) and with co-morbidities (diabetes, hypertension, dyslipidemia)
22
Q

Main Concerns with prescribing Anorexiants

A
  • CNS
  • Cardiovascular
  • Rebound effects upon discontinuation (regaining weight)
  • Commonly found as undeclared ingredients in dietary supplements
23
Q

Dimethylamylamine

A

-> Risk may include Heart Attack and more

24
Q

Other Anorexiants

A

1) OTC decongestants:
- Pseudoephedrine
- Phenylephrine
- (Phenylpropanolamine)

2) GLP-1 analogs:
- Liraglutide (Saxenda)

3) Absorption inhibitors:
- Orlistat (Xenical, ALLI)